Ticaflow Tablet 60 mg contains Ticagrelor, a potent oral antiplatelet medication used to prevent blood clots in patients with a history of acute coronary syndrome (ACS) or other cardiovascular risks. Ticagrelor belongs to the P2Y12 receptor antagonist class, which works by inhibiting platelet aggregation, thereby reducing the risk of heart attack, stroke, and stent thrombosis.

Ticaflow Tablet 60 mg is commonly prescribed for long-term secondary prevention after an acute coronary event or percutaneous coronary intervention (PCI). Its oral formulation provides convenient twice-daily dosing, allowing sustained platelet inhibition and better protection against thrombotic complications.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Ticaflow Tablet 60 mg is indicated for:

• Secondary prevention of cardiovascular events: Reduces the risk of recurrent heart attack, stroke, or cardiovascular death in patients with a history of ACS

• Post-percutaneous coronary intervention (PCI): Helps prevent stent thrombosis and complications after stent placement

• Patients intolerant to other antiplatelet drugs: Provides an effective alternative for those unable to take clopidogrel or other P2Y12 inhibitors

• Long-term management: Supports ongoing cardiovascular protection in patients at high risk of thrombotic events

This medication is intended for prolonged therapy under strict medical supervision to optimize cardiovascular outcomes.

Mechanism of Action

Ticagrelor in Ticaflow Tablet 60 mg works by reversibly inhibiting the P2Y12 receptor on platelets, preventing adenosine diphosphate (ADP)-mediated platelet activation and aggregation:

• Prevents platelet clumping: Reduces thrombus formation in coronary arteries

• Rapid and sustained antiplatelet effect: Provides effective platelet inhibition within hours of administration

• Reversible binding: Allows better control of platelet activity compared to irreversible P2Y12 inhibitors

• Synergistic with aspirin: Often used with low-dose aspirin to enhance cardiovascular protection

This mechanism helps minimize the risk of blood clots, lowering the likelihood of heart attacks, strokes, and other thrombotic complications in high-risk patients.

Dosage and Administration

• The recommended dose is 60 mg orally twice daily, with or without food

• Tablets should be swallowed whole with water

• Typically prescribed in combination with low-dose aspirin (75–100 mg daily) unless contraindicated

• Do not discontinue therapy abruptly, as sudden cessation may increase the risk of thrombotic events

• Dose adjustments may be needed for patients with renal or hepatic impairment, according to physician guidance

Precautions and Warnings

• Bleeding risk: Ticagrelor increases the risk of bleeding, including gastrointestinal, intracranial, or post-surgical bleeding

• Surgery: Inform your surgeon before any procedure; Ticagrelor may need temporary discontinuation

• Drug interactions: Avoid strong CYP3A4 inhibitors or inducers, as they may alter Ticagrelor levels

• Dyspnea: Mild shortness of breath may occur; seek medical advice if severe or persistent

• Pregnancy and breastfeeding: Use only if clearly necessary and under strict medical supervision

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Ticaflow Tablet 60 mg is generally well tolerated. Common side effects include:

• Mild bleeding, such as nosebleeds, gum bleeding, or easy bruising

• Shortness of breath or mild dyspnea

• Headache or dizziness

• Gastrointestinal disturbances, including nausea or diarrhea

• Rare: severe bleeding, allergic reactions, or arrhythmias

Seek immediate medical attention if you experience severe bleeding, chest pain, or unexplained bruising.

Storage

Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.

Ticaflow Tablet 60 mg provides effective long-term antiplatelet therapy, reducing the risk of recurrent cardiovascular events and supporting heart health in patients with a history of ACS or high thrombotic risk.